Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+45.1%
5Y CAGR+71.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+45.1%/yr
Annual compound
5Y CAGR
+71.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$138.23M+21.2%
2024$114.02M+86.5%
2023$61.14M+35.2%
2022$45.24M+131.0%
2021$19.58M+109.5%
2020$9.35M-1.6%
2019$9.50M-